Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

28Feb 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

More
20Feb 2024

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024

More

Financial Calendar

10Jan 2024

42nd Annual J.P. Morgan Healthcare Conference

Add to Calendar
08Nov 2023

Amphastar Third Quarter Earnings Call

Add to Calendar
08Aug 2023

Amphastar Second Quarter Earnings Call

Add to Calendar
09May 2023

Amphastar First Quarter Earnings Call

Add to Calendar
24Apr 2023
28Feb 2023

Amphastar Fourth Quarter Earnings Call

Add to Calendar
07Nov 2022

Amphastar Third Quarter Earnings Call

Add to Calendar
08Aug 2022

Amphastar Second Quarter Earnings Call

Add to Calendar
08Jun 2022

Jefferies Healthcare Conference

Add to Calendar
09May 2022

Amphastar First Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.
Youtube